GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson's Formulation With Endopure Life Sciences

GB Sciences' Licensing Deal with Endopure Life Sciences will also include Rights to Develop and Market GB Sciences' Cannabinoid-based Treatments for a Suite of Neurological Disorders LAS VEGAS, NV /… [+6020 chars]

GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson's Formulation With Endopure Life Sciences

GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson's Formulation With Endopure Life Sciences

GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson's Formulation With Endopure Life Sciences

GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson's Formulation With Endopure Life Sciences
GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson's Formulation With Endopure Life Sciences
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute
Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leadi
Weekly Climate and Energy News Roundup #603

Gut Feeling Off This Monsoon? This Humble Moong Water Recipe Is Your Answer
As monsoon sets in, respiratory, malaria drugs see demand rise